Hybridoma cell lines which produce monoclonal antibodies having the properties of monoclonal antibody 100-310 and the monoclonal antibodies produced by these hybridoma cell lines
US5565356A · kind A · utility
1Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 1994 |
| Grant date | Oct 15, 1996 |
| Priority date | — |
| Expiry date | Jul 11, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/1063
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Monoclonal antibody 100-310 is found to be reactive against colon cancer cells and would therefore be useful for diagnostic imaging and treatment of colon cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.